PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International Laboratories Ltd (Proteomics...
Proteomics and Dimerix partner to improve the treatment of kidney disease
Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ), a leader in providing predictive diagnostics, is pleased to announce that it has partnered with innovative drug developer Dimerix Limited (ASX:DXB) to improve the treatment of chronic kidney disease (CKD).